US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Biotest AG

24.23

0.0000

Volume:- -

Turnover:- -

Market Cap:1.92B

PE:-71.16

High:24.23

Open:24.23

Low:24.23

Close:24.23

52wk High:24.23

52wk Low:22.80

Shares:79.14M

Float Shares:40.70M

Volume Ratio:1.62

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3405

EPS(LYR):0.3454

ROE:-4.72%

ROA:0.52%

PB:3.19

PE(LYR):70.16

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Biotest AG

Exchange:

PINK LIMITED

Establishment Date:

1946

Employees:

2495

Office Location:

Landsteinerstraße 5,Dreieich,Hessen,Germany

Website:

- -

Zip Code:

63303

Phone:

Fax:

49 61 03 801 150

Introduction:

Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company's products also comprise Cytotect CP biotest for cytomegalovirus infections; Fovepta for hepatitis B prophylaxis in neonates; Hepatect for prophylaxis of hepatitis B reinfection; Intratect and Yimmugo for primary immune and secondary antibody deficiency syndromes and autoimmune diseases, as well as neurological indications; Varitect for the treatment of varicella zoster virus infections; and Zutectra for hepatitis B re-infection prophylaxis after liver transplantation. In addition, it provides Albiomin and Biseko to restore and maintain circulating blood volume; Cofact for the treatment of clotting factors deficiency; Fibrinogen to treat congenital fibrinogen deficiency; Trimodulin for the community-acquired pneumonia and COVID-19; and Pentaglobin to treat bacterial infections. The company was formerly known as Biotest Serum-Institut GmbH and changed its name to Biotest Aktiengesellschaft in 1986. The company was founded in 1946 and is headquartered in Dreieich, Germany. Biotest Aktiengesellschaft operates as a subsidiary of Grifols, S.A.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BTTAY/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BTTAY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BTTAY\",,,,,undefined,":{"symbol":"BTTAY","market":"US","secType":"STK","nameCN":"Biotest AG","latestPrice":24.23,"timestamp":1771621200000,"preClose":24.23,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":40703195,"shares":79142904,"eps":-0.340513,"marketStatus":"Market Closed","change":0,"latestTime":"02-20 16:00:00 EST Delay","open":24.23,"high":24.23,"low":24.23,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.340513,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0.5,"exchange":"PINK LIMITED","adjPreClose":24.23,"volumeRatio":1.6157574453861927},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BTTAY\",,,,,undefined,":{"symbol":"BTTAY","floatShares":40703195,"roa":"0.52%","roe":"-4.72%","lyrEps":0.34535,"volumeRatio":1.6157574453861927,"shares":79142904,"dividePrice":0,"high":24.23,"amplitude":0,"preClose":24.23,"low":24.23,"week52Low":22.8,"pbRate":"3.19","psRate":"2.56","week52High":24.23,"institutionHeld":0,"latestPrice":24.23,"eps":-0.340513,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.340513,"open":24.23,"prevYearClose":24.23,"prevWeekClose":24.23,"prevMonthClose":24.23,"prevQuarterClose":24.23,"fiveDayClose":24.23,"twentyDayClose":24.23,"sixtyDayClose":24.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BTTAY\",params:#limit:5,,,undefined,":[{"date":"2025-07-07","symbol":"BTTAY","amount":0.023452,"announcedDate":"2025-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-07","name":"Biotest AG","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-22","payableDate":"2025-07-07","currency":"USD","dateTimestamp":1751860800000,"payDate":"2025-07-22"},{"market":"US","date":"2025-05-12","symbol":"BTTAY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-03-31","symbol":"BTTAY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"BTTAY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"","actualEps":null},{"date":"2024-08-06","symbol":"BTTAY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722931200000,"name":null,"time":"Pre-Market","dateTimestamp":1722916800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BTTAY\",market:\"US\",,,undefined,":[{"executeDate":"2025-07-07","recordDate":"2025-07-07","paymentDate":"2025-07-22","value":0.023452,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BTTAY\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":4481757,"yearFounded":1946,"employeeNum":2495,"address":"Landsteinerstraße 5,Dreieich,Hessen,Germany","zipCode":"63303","officePhone":"49 61 03 801 0","officeFax":"49 61 03 801 150"},"stockCompanyDetail":{"description":"Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company's products also comprise Cytotect CP biotest for cytomegalovirus infections; Fovepta for hepatitis B prophylaxis in neonates; Hepatect for prophylaxis of hepatitis B reinfection; Intratect and Yimmugo for primary immune and secondary antibody deficiency syndromes and autoimmune diseases, as well as neurological indications; Varitect for the treatment of varicella zoster virus infections; and Zutectra for hepatitis B re-infection prophylaxis after liver transplantation. In addition, it provides Albiomin and Biseko to restore and maintain circulating blood volume; Cofact for the treatment of clotting factors deficiency; Fibrinogen to treat congenital fibrinogen deficiency; Trimodulin for the community-acquired pneumonia and COVID-19; and Pentaglobin to treat bacterial infections. The company was formerly known as Biotest Serum-Institut GmbH and changed its name to Biotest Aktiengesellschaft in 1986. The company was founded in 1946 and is headquartered in Dreieich, Germany. Biotest Aktiengesellschaft operates as a subsidiary of Grifols, S.A.","exchange":"PINK LIMITED","name":"Biotest AG","nameEN":"Biotest AG"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BTTAY\",market:\"US\",,,undefined,":null}}